CLINICAL_TRIALS
withdrawal
· 2025-09-29
Clinical Trial Update: Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy
Summary
Expanded access IND for Hope Biosciences' autologous adipose-derived mesenchymal stem cells to treat cerebral palsy is no longer available.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hope Biosciences Research Foundation | Conditions: Cerebral Palsy | Status: NO_LONGER_AVAILABLE